Evidence map›Paper›PMID 39065411›Full record

ReviewPlants (Basel, Switzerland)2024

CRISPR/Cas-Mediated Genome Engineering in Plants: Application and Prospectives.

Swetaleena Mishra, Subhendu Nayak, Narendra Tuteja, Sowmya Poosapati, Durga Madhab Swain, Ranjan Kumar Sahoo

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Swetaleena MishraDepartment of Biotechnology, Centurion University of Technology and Management, Bhubaneswar 752050, India.
Subhendu NayakVidya USA Corporation, Otis Stone Hunter Road, Bunnell, FL 32100, USA.
Narendra TutejaPlant Molecular Biology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi 110067, India.
Sowmya PoosapatiPlant Biology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, USA.ORCID 0000-0002-1853-601X
Durga Madhab SwainMU Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0003-4904-1404
Ranjan Kumar SahooDepartment of Biotechnology, Centurion University of Technology and Management, Bhubaneswar 752050, India.ORCID 0000-0003-1063-6611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic engineering has become an essential element in developing climate-resilient crops and environmentally sustainable solutions to respond to the increasing need for global food security. Genome editing using CRISPR/Cas [Clustered regulatory interspaced short palindromic repeat (CRISPR)-associated protein (Cas)] technology is being applied to a variety of organisms, including plants. This technique has become popular because of its high specificity, effectiveness, and low production cost. Therefore, this technology has the potential to revolutionize agriculture and contribute to global food security. Over the past few years, increasing efforts have been seen in its application in developing higher-yielding, nutrition-rich, disease-resistant, and stress-tolerant "crops", fruits, and vegetables. Cas proteins such as Cas9, Cas12, Cas13, and Cas14, among others, have distinct architectures and have been used to create new genetic tools that improve features that are important for agriculture. The versatility of Cas has accelerated genomic analysis and facilitated the use of CRISPR/Cas to manipulate and alter nucleic acid sequences in cells of different organisms. This review provides the evolution of CRISPR technology exploring its mechanisms and contrasting it with traditional breeding and transgenic approaches to improve different aspects of stress tolerance. We have also discussed the CRISPR/Cas system and explored three Cas proteins that are currently known to exist: Cas12, Cas13, and Cas14 and their potential to generate foreign-DNA-free or non-transgenic crops that could be easily regulated for commercialization in most countries.

Indexed as

CRISPR-Cas systemcrop improvementgenome engineeringprime editing

Identifiers

PMID39065411
PMCPMC11279650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.